MadidiP., RossC.J.D., HaydenM.R.. Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: A case-control study. Clin Pharmacol Ther.2009; 85(1): 31–35.
2.
LamJ., KellyL., CiszkowskiC.. Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia. J Pediatr.2012; 160: 33–37.
3.
KellyL.E., ChaudhryS.A., RiederM.J.. A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milk. PLoS One.20138(7): e70073.
4.
BernardS., NevilleK.A., NguyenA.T.. Interethnic differences in genetic polymorphisms of CYP2D6 in the US population: Clinical implications. Oncologist.2006; 11: 126–35.
Acetaminophen and codeine phosphate oral solution [package insert].Amityville, NY: Hi-Tech Pharmacal Co. Inc.; March 2009.
8.
MadidiP., MorettiM., DjokanovicN.. Guidelines for maternal codeine use during breastfeeding. Can Fam Physician.2009; 55(11): 1077–1078.
9.
MadidiP., ShiraziF., WalterF.G.. Establishing causality of CNS depression in breastfed infants following maternal codeine use. Pediatr Drugs.2008; 10(6): 399–404.
10.
KorenG., CaimsJ., ChitayatD.. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet.2006; 368: 704.
11.
GascheY., DaaliY., FathiM.. Codeine intoxication associated with ultrarapid CYP2D6 metabolism. N Eng J Med.2004; 351: 2827–2831.
12.
WillmanS., EdgintonA.N., CoboekenK.. Risk to breastfed neonate from codeine treatment to the mother: A quantitative mechanistic modeling study. Nature.2009; 86(6): 634–643.
13.
LazaryanM., Shasha-ZigelmanC., DaganZ.. Codeine should not be prescribed for breastfeeding others or children under the age of 12. Acta Pediatr.2015; 104: 550–556.
14.
MadidiP., KorenG., CairnsJ.. Safety of codeine during breastfeeding: Fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine. Can Fam Physician.2007; 53: 33–35.